四环医药：私有化等新闻内容不属实
四环医药方面对智通财经 APP 表示：“私有化等新闻内容不属实，四环医药并未与华润集团或其他任何机构或组织商讨上述事项，亦没有计划将本集团私有化。”
智通财经 APP 获悉，针对网传华润集团正与四环医药（00460）私有化进行谈判，以及相关估值、私有化作价等信息，四环医药方面对智通财经 APP 表示：“私有化等新闻内容不属实，四环医药并未与华润集团或其他任何机构或组织商讨上述事项，亦没有计划将本集团私有化。”
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Like